Sarsys Balance Sheet Health

Financial Health criteria checks 5/6

Sarsys has a total shareholder equity of SEK914.0K and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK48.6M and SEK47.7M respectively.

Key information

0%

Debt to equity ratio

SEK 0

Debt

Interest coverage ration/a
CashSEK 3.99m
EquitySEK 914.00k
Total liabilitiesSEK 47.67m
Total assetsSEK 48.58m

Recent financial health updates

Recent updates

Does SARSYS-ASFT (NGM:SARS) Have A Healthy Balance Sheet?

Apr 21
Does SARSYS-ASFT (NGM:SARS) Have A Healthy Balance Sheet?

SARSYS-ASFT AB (publ)'s (NGM:SARS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 09
SARSYS-ASFT AB (publ)'s (NGM:SARS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Financial Position Analysis

Short Term Liabilities: SARS's short term assets (SEK26.6M) do not cover its short term liabilities (SEK40.6M).

Long Term Liabilities: SARS's short term assets (SEK26.6M) exceed its long term liabilities (SEK7.0M).


Debt to Equity History and Analysis

Debt Level: SARS is debt free.

Reducing Debt: SARS has no debt compared to 5 years ago when its debt to equity ratio was 40%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable SARS has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: SARS is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 67% per year.


Discover healthy companies